It is logical that younger, adult VHA patients would have a reduced risk of insulin initiation and mortality because the accumulation of comorbid conditions that contribute to poor health outcomes increases with aging and likely limits the ability to detect associations between PTSD improvement and T2D outcomes in those aged older than 50 years. This evidence concerns the gene INS and type 2 diabetes mellitus.